- Home
- CGEM vs IMOS Comparison
CGEM vs IMOS Comparison
Compare CGEM & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- IMOS
- Stock Information
- Founded
- CGEM 2016
- IMOS 1997
- Country
- CGEM United States
- IMOS Taiwan
- Employees
- CGEM N/A
- IMOS N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- IMOS Semiconductors
- Sector
- CGEM Health Care
- IMOS Technology
- Exchange
- CGEM Nasdaq
- IMOS Nasdaq
- Market Cap
- CGEM 482.7M
- IMOS 534.3M
- IPO Year
- CGEM 2021
- IMOS N/A
- Fundamental
- Price
- CGEM $6.12
- IMOS $19.18
- Analyst Decision
- CGEM Strong Buy
- IMOS
- Analyst Count
- CGEM 8
- IMOS 0
- Target Price
- CGEM $27.25
- IMOS N/A
- AVG Volume (30 Days)
- CGEM 544.0K
- IMOS 16.3K
- Earning Date
- CGEM 11-06-2025
- IMOS 11-04-2025
- Dividend Yield
- CGEM N/A
- IMOS 3.46%
- EPS Growth
- CGEM N/A
- IMOS N/A
- EPS
- CGEM N/A
- IMOS 0.01
- Revenue
- CGEM N/A
- IMOS $777,452,000.00
- Revenue This Year
- CGEM N/A
- IMOS $3.76
- Revenue Next Year
- CGEM N/A
- IMOS $5.93
- P/E Ratio
- CGEM N/A
- IMOS $111.87
- Revenue Growth
- CGEM N/A
- IMOS 0.89
- 52 Week Low
- CGEM $5.90
- IMOS $12.78
- 52 Week High
- CGEM $18.62
- IMOS $23.85
- Technical
- Relative Strength Index (RSI)
- CGEM 34.69
- IMOS 70.54
- Support Level
- CGEM $5.89
- IMOS $18.30
- Resistance Level
- CGEM $6.76
- IMOS $18.66
- Average True Range (ATR)
- CGEM 0.40
- IMOS 0.35
- MACD
- CGEM -0.10
- IMOS 0.29
- Stochastic Oscillator
- CGEM 12.95
- IMOS 99.98
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.